Pinned
Today, history has been made: NICE has approved teplizumab for use on the NHS in England and Wales.
Teplizumab is the first ever immunotherapy that can delay the onset of type 1 diabetes symptoms for people in the early stages of the condition.
For the first time, we’re not



















